Related Experiment Video
Updated: Aug 15, 2026
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
[Modulation of matrix metalloproteinase by dexamethasone in airway remodeling in asthmatic rats]
Yiming Yuan1, Zengli Wang, Birong Dong
1Department of Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China.
Objective:
To observe the effect of dexamethasone on airway remodeling and to explore the significance of the balance between matrix metalloproteinase and the tissue inhibitor of metalloproteinase.
Methods:
Thirty male Wistar rats were randomly divided into asthmatic group (n = 10), dexamethasone group (n = 10) and control group (n = 10). Lung tissues were sliced and stained with H. E. The parameters such as bronchial basement membrane perimeter(Pbm), total bronchial wall area(WAt), inner wall area(WAi) and smooth muscle area(WAm), which reflect the thickness of airway wall, were measured by image analysis system. The expression levels of MMP-2 and TIMP-1 mRNA in the lungs were assessed by semiquantitative reverse transcription-polymerase chain reaction.
Results:
1. WAt/Pbm, WAi/Pbm and WAm/Pbm in asthmatic group (25.3 +/- 2.1 microns 2/micron, 20.4 +/- 2.3 microns 2/micron, 4.2 +/- 2.0 microns 2/micron, respectively) were significantly higher than those in control group (20.8 +/- 1.3 microns 2/micron, 15.3 +/- 2.1 microns 2/micron, 3.1 +/- 1.1 microns 2/micron) (P < 0.01). The differences between those in control group and those in dexamethasone group (21.3 +/- 2.4 microns 2/micron, 14.2 +/- 2.5 microns 2/micron, 3.2 +/- 1.0 microns 2/micron) were not statistically significant (P > 0.05). 2. MMP-2 and TIMP-1mRNA levels in asthmatic group (0.68 +/- 0.14, 0.56 +/- 0.10) and dexamethasone group (0.37 +/- 0.11, 0.31 +/- 0.10) were significantly higher than those in control group (0.14 +/- 0.03, 0.11 +/- 0.05). The differences between asthmatic group and dexamethasone group were also significant (P < 0.01). 3. There was a significant positive correlation between MMP-2 and TIMP-1 mRNA in control group and dexamethasone group (r = 0.67, 0.58, P < 0.05), but not in asthmatic group (r = 0.24, P > 0.05).
Conclusion:
Dexamethasone could prevent airway remodeling by downregulating the expression of MMP-2 and TIMP-1 and restoring the balance between MMP-2 and TIMP-1.
Insights
Dexamethasone prevents airway remodeling by reducing matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of metalloproteinase-1 (TIMP-1) expression. This treatment helps restore the balance between these key proteins in asthma models.
Area of Science:
- Respiratory Medicine
- Molecular Biology
- Pharmacology
Context:
- Airway remodeling is a hallmark of chronic asthma, contributing to persistent airflow limitation.
- The balance between matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) plays a critical role in tissue homeostasis and remodeling.
- Understanding the molecular mechanisms underlying airway remodeling is crucial for developing effective therapeutic strategies.
Purpose:
- To investigate the impact of dexamethasone on airway remodeling in a rat asthma model.
- To explore the role of matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in dexamethasone's effects.
- To assess the influence of dexamethasone on the MMP-2/TIMP-1 balance in lung tissue.
Summary:
- Dexamethasone treatment did not significantly alter airway wall thickness parameters (WAt/Pbm, WAi/Pbm, WAm/Pbm) compared to controls.
- Both asthmatic and dexamethasone-treated rats showed elevated MMP-2 and TIMP-1 mRNA levels compared to controls, with significantly higher levels in asthmatic rats.
- A positive correlation between MMP-2 and TIMP-1 mRNA was observed in control and dexamethasone groups, but not in the asthmatic group.
Impact:
- Dexamethasone demonstrates a potential to prevent airway remodeling.
- The drug appears to exert its protective effects by downregulating MMP-2 and TIMP-1 expression.
- Restoring the MMP-2/TIMP-1 balance may be a key mechanism by which dexamethasone mitigates airway remodeling in asthma.
